Study to check the efficacy of Uttar Basti (administration of oil through urethra) and oral medicines in the management of Prostate Enlargement

A clinical study to assess the efficacy of a treatment module including Shodhana followed by Shamana in the management of Benign Prostatic Hyperplasia (Mutraghata)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/039994

Enrollment

Registered

2022-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with BPH Grade I, II or III. 2. Patients having classical signs and symptoms of Mutraghata. 3. Patients fit for Anulomana and Uttara Basti.

Exclusion criteria

Exclusion criteria: 1. Age below 40 years or above 80 years 2. Patients diagnosed with BPH Grade IV 3. Patients with malignancy, congenital deformities of urogenital tract or any pathology other than BPH 4. Patients with Diabetes Mellitus, Hypertension, Renal disorders or any other systemic disease 5. Patients unfit for Anulomana and Uttara Basti

Design outcomes

Primary

Measure	Time frame
Patient is able to maintain normal urine flowTimepoint: 0th Day, 21st Day, 41st Day, 60th Day	—

Secondary

Measure	Time frame
Improvement in International Prostate Symptom Score (IPSS)Timepoint: 0th Day, 21st Day, 41st Day, 60th Day;Reduction in Prostate sizeTimepoint: 0th Day, 60th Day;Reduction in Prostate WeightTimepoint: 0th Day, 60th Day	—

Countries

India

Contacts

Public ContactProf Dr Anandaraman PV

All India Institute of Ayurveda

drprasanthd@gmail.com9895174060

Outcome results